Cybin CEO Doug Drysdale, Dr. David Nutt & Dr. John Krystal Discuss the Psychedelic Landscape
Cybin CEO Doug Drysdale, Dr. David Nutt & Dr. John Krystal Discuss the Psychedelic Landscape
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Cybin CEO Doug Drysdale, Dr. David Nutt & Dr. John Krystal Discuss the Psychedelic Landscape

Cybin CEO Doug Drysdale, Dr. David Nutt & Dr. John Krystal Discuss the Psychedelic Landscape

|
Cybin CEO Doug Drysdale & Deepak Chopra Talk about Their Partnership & The Benefits of Psychedelics

Cybin CEO Doug Drysdale & Deepak Chopra Talk about Their Partnership & The Benefits of Psychedelics

|
Why Is Cybin Investing So Heavily In Developing Novel Psychedelic Molecules? - CEO Doug Drysdale

Why Is Cybin Investing So Heavily In Developing Novel Psychedelic Molecules? - CEO Doug Drysdale

|
🧠 Tim speaks to Professor David Nutt about psilocybin trials, his views on drug reform and Sentia

🧠 Tim speaks to Professor David Nutt about psilocybin trials, his views on drug reform and Sentia

|
Cybin: Goldie Hawn Asks If SSRIs Can be Paired with Psychedelic Therapeutics.

Cybin: Goldie Hawn Asks If SSRIs Can be Paired with Psychedelic Therapeutics.

|
Psychedelics and Addiction with Professor David Nutt

Psychedelics and Addiction with Professor David Nutt

|
🧠 Tim speaks to Professor David Nutt about his psilocybin trials, drug reform and his new drink

🧠 Tim speaks to Professor David Nutt about his psilocybin trials, drug reform and his new drink

|
Cybin Inc. (NEO:CYBN) (NYSE:CYBN) CEO Doug Drysdale - RICH TV LIVE

Cybin Inc. (NEO:CYBN) (NYSE:CYBN) CEO Doug Drysdale - RICH TV LIVE

|
David Nutt on “illegal” drugs and the future of psychiatry

David Nutt on “illegal” drugs and the future of psychiatry

|
Your Brain On Cannabis: Why It’s Bad For Mental Health & How It Causes Psychosis | Dr. John Krystal

Your Brain On Cannabis: Why It’s Bad For Mental Health & How It Causes Psychosis | Dr. John Krystal

|
Five Telling Takeways from Benzinga Psychedelics Capital Conference

Five Telling Takeways from Benzinga Psychedelics Capital Conference

|
Beyond Innovation S3: John Krystal, Yale University

Beyond Innovation S3: John Krystal, Yale University

|
prof. David Nutt - The psychedelic revolution in neuroscience and psychiatry #MariaMyśli

prof. David Nutt - The psychedelic revolution in neuroscience and psychiatry #MariaMyśli

|
Professor David Nutt, Drug Science, calls upon the UK government to reschedule psilocybin

Professor David Nutt, Drug Science, calls upon the UK government to reschedule psilocybin

|
Cybin's Mission is what Drives the Passion Behind Our Team

Cybin's Mission is what Drives the Passion Behind Our Team

|
Dr. Robert Malenka Discusses the Future of Medicinal Psychedelics

Dr. Robert Malenka Discusses the Future of Medicinal Psychedelics

|
David Nutt: Founder of Drug Science | TT22

David Nutt: Founder of Drug Science | TT22

|
BioPub Interview with Christopher Moreau and Dr. David Nutt hosted by Dr. KSS.

BioPub Interview with Christopher Moreau and Dr. David Nutt hosted by Dr. KSS.

|
Professor David Nutt – Rethinking Psychopharmacology | Nudgestock 2021

Professor David Nutt – Rethinking Psychopharmacology | Nudgestock 2021

|
Psychedelics as Therapeutics - Robert Malenka at BrainMind

Psychedelics as Therapeutics - Robert Malenka at BrainMind

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa